Press & Releases

Press Release, April 24 -23
Change of focus and cost savings initiated

Press Release, March 20 -23
CFO Svein Martin Bjørnstad acquires shares

Press Release, Feb 20 -23
Carasent ASA: Board member buys shares

Press Release, Oct 28 -22
Carasent ASA: The new CEO Daniel Öhman, buys shares
Carasent in brief
Carasent develops and provides the most flexible clinical business support available on the Nordic market today. Our core value proposition consists of EHR solutions and a broad ecosystem of integrated services supporting the digital transformation of healthcare and improving the everyday life of healthcare staff. Our customers are primarily private providers within primary and specialist care, mental health and occupational health.
Today, Carasent consists of around 150+ employees, working from five offices in Norway and Sweden, and is growing rapidly both organically and through acquisitions. Our growth strategy is built on three dimensions: expanding products & services, new segments and new geographies.
- Founded in 1997 (as Apptix ASA)
- Listed on Oslo Stock Exchange
- +150 Employees
Quarterly and Annual Reports
Q1, 2023
Presentation
Q1, 2023
Earnings Announcement
Q1, 2023 (May 4)
Link to presentation/webcast
Annual Report, 2022
Annual Report
Annual Report, 2022
ESEF Format
Other Reports and Presentations
>> Attached below please find the Calling Notice and attachments for the Annual General Meeting on May 3, 2023.
For further details please contact:
Petri Nemi, Chairman of the Board Tel: +358 40 051 1493, or Svein Martin Bjørnstad, CFO Tel: +47 979 69 493>
Webcast recording and presentation
Update on new focus for Webdoc and cost savings
Calling Notice
Calling Notice for Annual General Meeting, May, 2023
Nomination Mandate
Mandate for the nomination committee
Nomination Proposal
Proposal for election of Board Directors, May 3, 2023
Renumeration Report
Management Renumeration Report 2022
Financial Calendar
Presentation of Q4 earnings, INVITATION HERE >>
Presentation of annual report 2022
Annual General Meeting
Presentation of earnings Q1
Presentation of half-yearly report
Presentation of earnings Q3
Presentation of earnings Q4